INS and COVID-19: Many molecular mechanisms have been advocated to explain a possible effect of metformin on COVID-19, such as its well-established insulin-sensitizing action or possible anti-inflammatory or antiviral properties [48], in a similar fashion to the possible effect that has been proposed for metformin on influenza-related complications [49].